---
title: "China BlueChemical Schedules Board Meeting to Approve Interim Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294796889.md"
description: "China BlueChemical (HK:3983) announced that its board of directors will convene on August 18-19, 2026, to review corporate performance and approve the interim results for the six months ended June 30, 2026. This meeting signals the forthcoming release of half-year financial figures, which are expected to shape investor expectations regarding the company's operational and financial trajectory."
datetime: "2026-08-04T09:12:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294796889.md)
  - [en](https://longbridge.com/en/news/294796889.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294796889.md)
generator: "portal-rs"
---

# China BlueChemical Schedules Board Meeting to Approve Interim Results

China BlueChemical ( (HK:3983) ) has issued an update.

China BlueChemical Ltd., a PRC-incorporated joint stock company listed in Hong Kong under stock code 3983, has announced that its board of directors will convene in mid-August to review corporate performance. The company’s governance framework includes a mix of executive, non-executive and independent non-executive directors, reflecting its adherence to Hong Kong corporate governance standards.

The board meeting will be held from 18 to 19 August 2026 to consider and approve the interim results for the six months ended 30 June 2026 for publication. The scheduled review signals the forthcoming release of half-year financial figures, an event likely to shape investor expectations and provide fresh insight into the company’s operational and financial trajectory for the rest of the year.

**More about China BlueChemical**

China BlueChemical Ltd. is a joint stock limited company incorporated in the People’s Republic of China and listed in Hong Kong under stock code 3983. The company operates in the chemical sector and oversees a group of subsidiaries, with a board comprising executive, non-executive and independent non-executive directors based in Beijing, reflecting its governance and market presence.

The board structure, including executive directors Hou Xiaofeng and Rao Shicai, non-executive directors Shao Lihua and He Qizhong, and independent non-executive directors Lin Feng, Xie Dong and Yang Wanhong, underpins the company’s compliance with Hong Kong listing rules and corporate governance norms.

**Average Trading Volume:** 5,863,483

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$9.77B

Learn more about 3983 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CBLUY.US](https://longbridge.com/en/quote/CBLUY.US.md)
- [03983.HK](https://longbridge.com/en/quote/03983.HK.md)

## Related News & Research

- [Essex Property Trust declares Q3 2026 dividend of R$ 0.89 per unit](https://longbridge.com/en/news/298322539.md)
- [Benfica Futebol SAD corrects AGM date to Oct. 1, 2026 from Sept. 30, 2026](https://longbridge.com/en/news/298497181.md)
- [Hvidbjerg Bank launches employee share program effective Oct. 1, 2026](https://longbridge.com/en/news/298410340.md)
- [REG - FIL Limited SEGRO PLC Prologis, Inc. - Form 8.3 - PROLOGIS INC](https://longbridge.com/en/news/298595317.md)
- [Tecnoglass declares $0.15 quarterly dividend for Q3 2026](https://longbridge.com/en/news/298582392.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**